Vulvodynia Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Type ( Local Anesthetics, Anticonvulsants, Tricyclic Antidepressants, Antimicrobials, Hormone Creams, Nerve Blocks, Others ); Distribution Channel ( Hospital Pharmacies, Online Pharmacies, Retail Pharmacies ) and Geography
Report Code: TIPRE00009009 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
The external female genital area is called the vulva. Pain that affects this area is very common. Vulvodynia is pain that lasts for 3 months or longer and is not caused by an infection, skin disorder, or other medical condition.
MARKET DYNAMICS
It is estimated that approximately 15 percent of women will suffer with chronic vulvar pain at some point in their lives. As a result of this there is the constant need for the treatment, which in turn will drive the market. However, poor awareness about the treatment may impede the market growth.
MARKET SCOPE
The "Global Vulvodynia Treatment Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Vulvodynia Treatment Market with detailed market segmentation by, drug type, distribution channel and geography. The Global Vulvodynia Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Vulvodynia Treatment Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Vulvodynia Treatment Market is segmented on the basis of drug type and distribution channel. Based on the type of the drug, the global market is segregated into local anesthetics, anticonvulsants, tricyclic antidepressants, antimicrobials, hormone creams, nerve blocks, and others. Based on the distribution channel, the market is categorized into hospital pharmacies, online pharmacies, and retail pharmacies. ?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Vulvodynia Treatment Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Vulvodynia Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Vulvodynia Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Vulvodynia Treatment Market in these regions.
The report covers key developments in the Vulvodynia Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Vulvodynia Treatment Market are anticipated to lucrative growth opportunities in the future with the rising demand for Vulvodynia Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Vulvodynia Treatment Market.
The report also includes the profiles of key Vulvodynia Treatment Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Sanofi Aventis
- Eli Lilly and Company
- Depomed Inc.
- Janssen Pharmaceuticals, Inc.
- Noven Pharmaceuticals, Inc.
- Upsher-Smith Laboratories, LLC
- National Vulvodynia Association
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.
The external female genital area is called the vulva. Pain that affects this area is very common. Vulvodynia is pain that lasts for 3 months or longer and is not caused by an infection, skin disorder, or other medical condition.
MARKET DYNAMICS
It is estimated that approximately 15 percent of women will suffer with chronic vulvar pain at some point in their lives. As a result of this there is the constant need for the treatment, which in turn will drive the market. However, poor awareness about the treatment may impede the market growth.
MARKET SCOPE
The "Global Vulvodynia Treatment Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Vulvodynia Treatment Market with detailed market segmentation by, drug type, distribution channel and geography. The Global Vulvodynia Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Vulvodynia Treatment Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Vulvodynia Treatment Market is segmented on the basis of drug type and distribution channel. Based on the type of the drug, the global market is segregated into local anesthetics, anticonvulsants, tricyclic antidepressants, antimicrobials, hormone creams, nerve blocks, and others. Based on the distribution channel, the market is categorized into hospital pharmacies, online pharmacies, and retail pharmacies. ?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Vulvodynia Treatment Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Vulvodynia Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Vulvodynia Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Vulvodynia Treatment Market in these regions.
The report covers key developments in the Vulvodynia Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Vulvodynia Treatment Market are anticipated to lucrative growth opportunities in the future with the rising demand for Vulvodynia Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Vulvodynia Treatment Market.
The report also includes the profiles of key Vulvodynia Treatment Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Sanofi Aventis
- Eli Lilly and Company
- Depomed Inc.
- Janssen Pharmaceuticals, Inc.
- Noven Pharmaceuticals, Inc.
- Upsher-Smith Laboratories, LLC
- National Vulvodynia Association
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vulvodynia Treatment Market - By Drug Type
1.3.2 Vulvodynia Treatment Market - By Distribution Channel
1.3.3 Vulvodynia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VULVODYNIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VULVODYNIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. VULVODYNIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. VULVODYNIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. VULVODYNIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VULVODYNIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. LOCAL ANESTHETICS
7.3.1. Overview
7.3.2. Local Anesthetics Market Forecast and Analysis
7.4. ANTICONVULSANTS
7.4.1. Overview
7.4.2. Anticonvulsants Market Forecast and Analysis
7.5. TRICYCLIC ANTIDEPRESSANTS
7.5.1. Overview
7.5.2. Tricyclic Antidepressants Market Forecast and Analysis
7.6. ANTIMICROBIALS
7.6.1. Overview
7.6.2. Antimicrobials Market Forecast and Analysis
7.7. HORMONE CREAMS
7.7.1. Overview
7.7.2. Hormone Creams Market Forecast and Analysis
7.8. NERVE BLOCKS
7.8.1. Overview
7.8.2. Nerve Blocks Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. VULVODYNIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. RETAIL PHARMACIES
8.5.1. Overview
8.5.2. Retail Pharmacies Market Forecast and Analysis
9. VULVODYNIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Vulvodynia Treatment Market Overview
9.1.2 North America Vulvodynia Treatment Market Forecasts and Analysis
9.1.3 North America Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Vulvodynia Treatment Market
9.1.5.1.1 United States Vulvodynia Treatment Market by Drug Type
9.1.5.1.2 United States Vulvodynia Treatment Market by Distribution Channel
9.1.5.2 Canada Vulvodynia Treatment Market
9.1.5.2.1 Canada Vulvodynia Treatment Market by Drug Type
9.1.5.2.2 Canada Vulvodynia Treatment Market by Distribution Channel
9.1.5.3 Mexico Vulvodynia Treatment Market
9.1.5.3.1 Mexico Vulvodynia Treatment Market by Drug Type
9.1.5.3.2 Mexico Vulvodynia Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Vulvodynia Treatment Market Overview
9.2.2 Europe Vulvodynia Treatment Market Forecasts and Analysis
9.2.3 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Vulvodynia Treatment Market
9.2.5.1.1 Germany Vulvodynia Treatment Market by Drug Type
9.2.5.1.2 Germany Vulvodynia Treatment Market by Distribution Channel
9.2.5.2 France Vulvodynia Treatment Market
9.2.5.2.1 France Vulvodynia Treatment Market by Drug Type
9.2.5.2.2 France Vulvodynia Treatment Market by Distribution Channel
9.2.5.3 Italy Vulvodynia Treatment Market
9.2.5.3.1 Italy Vulvodynia Treatment Market by Drug Type
9.2.5.3.2 Italy Vulvodynia Treatment Market by Distribution Channel
9.2.5.4 Spain Vulvodynia Treatment Market
9.2.5.4.1 Spain Vulvodynia Treatment Market by Drug Type
9.2.5.4.2 Spain Vulvodynia Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Vulvodynia Treatment Market
9.2.5.5.1 United Kingdom Vulvodynia Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Vulvodynia Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Vulvodynia Treatment Market Overview
9.3.2 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Vulvodynia Treatment Market
9.3.5.1.1 Australia Vulvodynia Treatment Market by Drug Type
9.3.5.1.2 Australia Vulvodynia Treatment Market by Distribution Channel
9.3.5.2 China Vulvodynia Treatment Market
9.3.5.2.1 China Vulvodynia Treatment Market by Drug Type
9.3.5.2.2 China Vulvodynia Treatment Market by Distribution Channel
9.3.5.3 India Vulvodynia Treatment Market
9.3.5.3.1 India Vulvodynia Treatment Market by Drug Type
9.3.5.3.2 India Vulvodynia Treatment Market by Distribution Channel
9.3.5.4 Japan Vulvodynia Treatment Market
9.3.5.4.1 Japan Vulvodynia Treatment Market by Drug Type
9.3.5.4.2 Japan Vulvodynia Treatment Market by Distribution Channel
9.3.5.5 South Korea Vulvodynia Treatment Market
9.3.5.5.1 South Korea Vulvodynia Treatment Market by Drug Type
9.3.5.5.2 South Korea Vulvodynia Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Vulvodynia Treatment Market Overview
9.4.2 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Vulvodynia Treatment Market
9.4.5.1.1 South Africa Vulvodynia Treatment Market by Drug Type
9.4.5.1.2 South Africa Vulvodynia Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Vulvodynia Treatment Market
9.4.5.2.1 Saudi Arabia Vulvodynia Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Vulvodynia Treatment Market by Distribution Channel
9.4.5.3 U.A.E Vulvodynia Treatment Market
9.4.5.3.1 U.A.E Vulvodynia Treatment Market by Drug Type
9.4.5.3.2 U.A.E Vulvodynia Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Vulvodynia Treatment Market Overview
9.5.2 South and Central America Vulvodynia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Vulvodynia Treatment Market
9.5.5.1.1 Brazil Vulvodynia Treatment Market by Drug Type
9.5.5.1.2 Brazil Vulvodynia Treatment Market by Distribution Channel
9.5.5.2 Argentina Vulvodynia Treatment Market
9.5.5.2.1 Argentina Vulvodynia Treatment Market by Drug Type
9.5.5.2.2 Argentina Vulvodynia Treatment Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. VULVODYNIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI AVENTIS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. DEPOMED INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JANSSEN PHARMACEUTICALS, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVEN PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. UPSHER-SMITH LABORATORIES, LLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NATIONAL VULVODYNIA ASSOCIATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vulvodynia Treatment Market - By Drug Type
1.3.2 Vulvodynia Treatment Market - By Distribution Channel
1.3.3 Vulvodynia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VULVODYNIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VULVODYNIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. VULVODYNIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. VULVODYNIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. VULVODYNIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VULVODYNIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. LOCAL ANESTHETICS
7.3.1. Overview
7.3.2. Local Anesthetics Market Forecast and Analysis
7.4. ANTICONVULSANTS
7.4.1. Overview
7.4.2. Anticonvulsants Market Forecast and Analysis
7.5. TRICYCLIC ANTIDEPRESSANTS
7.5.1. Overview
7.5.2. Tricyclic Antidepressants Market Forecast and Analysis
7.6. ANTIMICROBIALS
7.6.1. Overview
7.6.2. Antimicrobials Market Forecast and Analysis
7.7. HORMONE CREAMS
7.7.1. Overview
7.7.2. Hormone Creams Market Forecast and Analysis
7.8. NERVE BLOCKS
7.8.1. Overview
7.8.2. Nerve Blocks Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. VULVODYNIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. RETAIL PHARMACIES
8.5.1. Overview
8.5.2. Retail Pharmacies Market Forecast and Analysis
9. VULVODYNIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Vulvodynia Treatment Market Overview
9.1.2 North America Vulvodynia Treatment Market Forecasts and Analysis
9.1.3 North America Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Vulvodynia Treatment Market
9.1.5.1.1 United States Vulvodynia Treatment Market by Drug Type
9.1.5.1.2 United States Vulvodynia Treatment Market by Distribution Channel
9.1.5.2 Canada Vulvodynia Treatment Market
9.1.5.2.1 Canada Vulvodynia Treatment Market by Drug Type
9.1.5.2.2 Canada Vulvodynia Treatment Market by Distribution Channel
9.1.5.3 Mexico Vulvodynia Treatment Market
9.1.5.3.1 Mexico Vulvodynia Treatment Market by Drug Type
9.1.5.3.2 Mexico Vulvodynia Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Vulvodynia Treatment Market Overview
9.2.2 Europe Vulvodynia Treatment Market Forecasts and Analysis
9.2.3 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Vulvodynia Treatment Market
9.2.5.1.1 Germany Vulvodynia Treatment Market by Drug Type
9.2.5.1.2 Germany Vulvodynia Treatment Market by Distribution Channel
9.2.5.2 France Vulvodynia Treatment Market
9.2.5.2.1 France Vulvodynia Treatment Market by Drug Type
9.2.5.2.2 France Vulvodynia Treatment Market by Distribution Channel
9.2.5.3 Italy Vulvodynia Treatment Market
9.2.5.3.1 Italy Vulvodynia Treatment Market by Drug Type
9.2.5.3.2 Italy Vulvodynia Treatment Market by Distribution Channel
9.2.5.4 Spain Vulvodynia Treatment Market
9.2.5.4.1 Spain Vulvodynia Treatment Market by Drug Type
9.2.5.4.2 Spain Vulvodynia Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Vulvodynia Treatment Market
9.2.5.5.1 United Kingdom Vulvodynia Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Vulvodynia Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Vulvodynia Treatment Market Overview
9.3.2 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Vulvodynia Treatment Market
9.3.5.1.1 Australia Vulvodynia Treatment Market by Drug Type
9.3.5.1.2 Australia Vulvodynia Treatment Market by Distribution Channel
9.3.5.2 China Vulvodynia Treatment Market
9.3.5.2.1 China Vulvodynia Treatment Market by Drug Type
9.3.5.2.2 China Vulvodynia Treatment Market by Distribution Channel
9.3.5.3 India Vulvodynia Treatment Market
9.3.5.3.1 India Vulvodynia Treatment Market by Drug Type
9.3.5.3.2 India Vulvodynia Treatment Market by Distribution Channel
9.3.5.4 Japan Vulvodynia Treatment Market
9.3.5.4.1 Japan Vulvodynia Treatment Market by Drug Type
9.3.5.4.2 Japan Vulvodynia Treatment Market by Distribution Channel
9.3.5.5 South Korea Vulvodynia Treatment Market
9.3.5.5.1 South Korea Vulvodynia Treatment Market by Drug Type
9.3.5.5.2 South Korea Vulvodynia Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Vulvodynia Treatment Market Overview
9.4.2 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Vulvodynia Treatment Market
9.4.5.1.1 South Africa Vulvodynia Treatment Market by Drug Type
9.4.5.1.2 South Africa Vulvodynia Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Vulvodynia Treatment Market
9.4.5.2.1 Saudi Arabia Vulvodynia Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Vulvodynia Treatment Market by Distribution Channel
9.4.5.3 U.A.E Vulvodynia Treatment Market
9.4.5.3.1 U.A.E Vulvodynia Treatment Market by Drug Type
9.4.5.3.2 U.A.E Vulvodynia Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Vulvodynia Treatment Market Overview
9.5.2 South and Central America Vulvodynia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Vulvodynia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Vulvodynia Treatment Market
9.5.5.1.1 Brazil Vulvodynia Treatment Market by Drug Type
9.5.5.1.2 Brazil Vulvodynia Treatment Market by Distribution Channel
9.5.5.2 Argentina Vulvodynia Treatment Market
9.5.5.2.1 Argentina Vulvodynia Treatment Market by Drug Type
9.5.5.2.2 Argentina Vulvodynia Treatment Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. VULVODYNIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI AVENTIS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. DEPOMED INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JANSSEN PHARMACEUTICALS, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVEN PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. UPSHER-SMITH LABORATORIES, LLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NATIONAL VULVODYNIA ASSOCIATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Pfizer Inc.
2. Sanofi Aventis
3. Eli Lilly and Company
4. Depomed Inc.
5. Janssen Pharmaceuticals, Inc.
6. Noven Pharmaceuticals, Inc.
7. Upsher-Smith Laboratories, LLC
8. National Vulvodynia Association
1. Pfizer Inc.
2. Sanofi Aventis
3. Eli Lilly and Company
4. Depomed Inc.
5. Janssen Pharmaceuticals, Inc.
6. Noven Pharmaceuticals, Inc.
7. Upsher-Smith Laboratories, LLC
8. National Vulvodynia Association